Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles

Nanotoxicology

Volumn 9, Issue 4, 2015, Pages 462-473

  Li, Yang ^a,b   Italiani, Paola ^a   Casals, Eudald ^c   Tran, Ngoc ^c   Puntes, Victor F ^c   Boraschi, Diana ^a,b  

^a CNR   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

Author keywords

Endotoxin contamination; Interference; LAL assay; Nanoparticles

Indexed keywords

ENDOTOXIN; GOLD NANOPARTICLE; IRON OXIDE NANOPARTICLE; METAL OXIDE; NANOCOATING; NANOPARTICLE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; COLLOID; METAL NANOPARTICLE; OXIDE;

ARTICLE; COLLOID; CONTROLLED STUDY; ENDOTOXIN DETECTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIMULUS AMOEBOCYTE LYSATE ASSAY; NANOCHEMISTRY; PRIORITY JOURNAL; SURFACE PROPERTY; CATALYSIS; CHEMISTRY; FLUORESCENCE; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIA (MICROORGANISMS); LIMULUS AMOEBOCYTE;

CATALYSIS; COLLOIDS; ENDOTOXINS; FLUORESCENCE; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; OXIDES;

EID: 84929742910     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2014.948090     Document Type: Article

References (43)

1. Bastús NG, Comenge J, Puntes V. 2011. Kinetically controlled seeded growth synthesis of citrate-stabilized gold nanoparticles of up to 200 nm: size focusing versus Ostwald ripening. Langmuir 27: 11098-105.
2. Bastús NG, Merkoci F, Piella J, Puntes V. 2014. Synthesis of highly monodisperse citrate-stabilized silver nanoparticles of up to 200 nm: kinetic control and catalytic properties. Chem Mater 26:2836-46.
3. Bastús NG, Sánchez-Tilló E, Pujals S, Farrera C, Kogan MJ, Giralt E, et al. 2009. Peptides conjugated to gold nanoparticles induce macrophage activation. Mol Immunol 46:743-8.
4. Boraschi D, Duschl A. 2012. Immune system. In Fadeel B, Pietroiusti A, Shvedova AA, eds. Adverse Effects of Engineered Nanomaterials. Amsterdam: Academic Press, 169-84.
5. Daniel M-C, Astruc D. 2004. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104: 293-346.
6. Danner RL, Elin R, Hosseini J, Wesley RA, Reilly JM, Parillo JE. 1991. Endotoxemia in human septic shock. Chest 99:169-75.
7. Dobrovolskaia MA, Neun BW, Clogston JD, Ding H, Ljubimova J, McNeil SE. 2010. Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations. Nanomedicine 5:555-62.
8. Dobrovolskaia MA, Germolec DR, Weaver JL. 2009. Evaluation of nanoparticle immunotoxicity. Nat Nanotech 4:411-14.
9. Dobrovolskaia MA, Neun BW, Clogston JD, Grossman JH, McNeil SE. 2013. Choice of method for endotoxin detection depends on nanoformulation. Nanomedicine. [Epub ahead of print]. doi:10.2217/nnm.13.157.
10. FDA. 1987. Guideline on validation of the Limulus Amebocyte Lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products, and medical devices. Silver Spring (MD): U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration.
11. Geraets L, Oomen AG, Schroeter JD, Coleman VA, Cassee FR. 2012. Tissue distribution of inhaled micro-And nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol Sci 127: 463-73.
12. Gosens I, Post JA, de la Fonteyne L, Jansen EH, Geus JW, Cassee FR, de Jong WH. 2010. Impact of agglomeration state of nano-And submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol 7:3-7.
13. Gumprecht RO, Sliepcevich CM. 1953. Scattering of light by large spherical particles. J Phys Chem 57:90-5.
14. Harada-Suzuki T, Morita T, Iwanaga S, Nakamura S, Niwa M. 1982. Further studies on the chromogenic substrate assay method for bacterial endotoxins using horseshoe crab (Tachypleus tridentatus) hemocyte lysate. J Biochem (Tokyo) 92:793-800.
15. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA, et al. 2009. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology 260:142-9.
16. Hussain S, Vanoirbeek JA, Hoet PH. 2012. Interactions of nanomaterials with the immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:169-83.
17. ISO. 2010. ISO/FDIS 29701: Nanotechnologies - Endotoxin test on nanomaterial samples for in vitro systems - Limulus amebocyte lysate (LAL) test.
18. Jana NR, Gearheart L, Murphy CJ. 2001. Seeding growth for size control of 5-40 nm diameter gold nanoparticles. Langmuir 17:6782-6.
19. Jolivet J, Massart R, Fruchart J. 1983. Synthesis and physicochemical study of non-surfactant magnetic colloids in an aqueous-medium. New J Chem 7:325-31.
20. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. 2007. Antimicrobial effects of silver nanoparticles. Nanomed Nanotech Biol Med 3:95-101.
21. Kucki M, Cavelius C, Kraegeloh A. 2013. Interference of silica nanoparticles with the traditional Limulus amebocyte lysate gel clot assay. Innate Immun 20:327-36.
22. Lieder R, Petersen PH, Sigurjónsson OE. 2013. Endotoxins - the invisible companion in biomaterials research. Tissue Eng Part B Rev 19: 391-402.
23. Liu AH. 2002. Endotoxin exposure in allergy and asthma: reconciling a paradox. J Allergy Clin Immunol 109:379-92.
24. Liu G, Gao J, Ai H, Chen X. 2013. Applications and potential toxicity of magnetic iron oxide nanoparticles. Small 9:1533-45.
25. Ma JS, Kim WJ, Kim JJ, Kim TJ, Ye SK, Song MD, et al. 2010. Gold nanoparticles attenuate LPS-induced NO production through the inhibition of NF-kB and IFN-b/STAT1 pathways in RAW264. 7 cells. Nitric Oxide 23:214-19.
26. Malyala P, Singh M. 2008. Endotoxin limits in formulations for preclinical research. J Pharm Sci 97:2041-4.
27. Massart R. 1981. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 17:1247-8.
28. Medzhitov R. 2001. Toll-like receptors and innate immunity. Nat Rev Immunol 1:135-45.
29. Morrison D, Ulevitch R. 1978. The effects of bacterial endotoxins on host mediation systems: a review. Am J Pathol 93:526-618.
30. Neun BW, Dobrovolskaia MA. 2011. Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LALbased assays. Methods Mol Biol 697:121-30.
31. Oostingh GJ, Casals E, Italiani P, Colognato R, Stritzinger R, Ponti J, et al. 2011. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part Fibre Toxicol 8:8. doi:10.1186/1743-8977-8-8.
32. Perros F, Lambrecht BN, Hammad H. 2011. TLR4 signalling in pulmonary stromal cells is critical for inflammation and immunity in the airways. Respir Res 12:125. doi:10.1186/1465-9921-12-125.
33. Pfaller T, Puntes V, Casals E, Duschl A, Oostingh GJ. 2009. In vitro investigation of immunomodulatory effects caused by engineered inorganic nanoparticles - the impact of experimental design and cell choice. Nanotoxicology 3:46-59.
34. Qu G, Liu S, Zhang S, Wang L, Wang X, Sun B, et al. 2013. Graphene oxide induces Toll-like Receptor 4 (TLR4)-dependent necrosis in macrophages. ACS Nano 7:5732-45.
35. Sellers H, Ulman A, Shnidman Y, Eilers JE. 1993. Structure and binding of alkanethiolates on gold and silver surfaces: implications for self-Assembled monolayers. J Am Chem Soc 115:9389-401.
36. Smulders S, Kaiser JP, Zuin S, Van Landuyt KL, Golanski L, Vanoirbeek J, et al. 2012. Contamination of nanoparticles by endotoxin: evaluation of different test methods. Part Fibre Toxicol 9:41. doi:10.1186/1743- 8977-9-41.
37. Sperling R, Parak W. 2010. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Phil Trans R Soc A 368:1333-83.
38. Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ. 2008. Biological applications of gold nanoparticles. Chem Soc Rev 37: 1896-908.
39. Turkevich J, Stevenson PC, Hillier J. 1955. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 11:55-75.
40. Twohy CW, Duran AP, Munson TE. 1984. Endotoxin contamination of parenteral drugs and radiopharmaceuticals as determined by the Limulus amebocyte lysate method. J Parenter Sci Technol 38: 190-201.
41. USP. 2005. Chapter 85: Bacterial endotoxins test. United States Pharmacopeia. Rockville: United States Pharmacopeial Convention.
42. Vallhov H, Qin J, Johansson SM, Ahlborg N, Muhammed MA, Scheynius A, Gabrielsson S. 2006. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett 6:1682-6.
43. Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J. 2010. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1a and IL-1b. Proc Natl Acad Sci USA 107: 19449-54.